THERAPY WITH CERTOLIZUMAB PEGOL AND OTHER TNF-A INHIBITORS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE CORRONA REGISTRY

被引：0
|
作者：
Pappas, D. A.
Etzel, C. J. [1 ]
Bedenbaugh, A. [2 ]
Tambiah, J. [3 ]
Greenberg, J. D. [4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] UCB Pharma, Smyrna, GA USA
[3] UCB, Smyrna, GA USA
[4] NYU, Sch Med, New York, NY USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.256
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS11
引用
收藏
页码：A43 / A43
页数：1
相关论文
共 50 条
  • [1] EFFECT OF SMOKING ON RESPONSE TO THERAPY WITH TNF-A INHIBITORS FOR RHEUMATOID ARTHRITIS: RESULTS FROM THE CORRONA REGISTRY
    Pala, O.
    Messing, S.
    Hopkins, A.
    Reed, G.
    Perez-Rivera, M.
    Acosta, M.
    Kremer, J. M.
    Lozada, C.
    Pappas, D. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 521 - 521
  • [2] EFFECT OF ALCOHOL ON RESPONSE TO THERAPY WITH TNF-A INHIBITORS FOR RHEUMATOID ARTHRITIS: RESULTS FROM CORRONA REGISTRY
    Pala, O.
    Messing, S.
    Hopkins, A.
    Reed, G.
    Perez-Rivera, M.
    Acosta, M.
    Kremer, J. M.
    Lozada, C.
    Pappas, D. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 369 - 369
  • [3] Effectiveness Of TNF-a Inhibitor Therapy Does Not Differ Between Elderly and Younger Patients With Rheumatoid Arthritis: Results From The Corrona Registry.
    Hopkins, Aviva C.
    Martinez-Marti, Melisa
    Reed, George W.
    He, Ping
    Greenberg, Jeffrey D.
    Lozada, Carlos J.
    Pala, Ozlem
    Kremer, Joel M.
    Pappas, Dimitrios A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S608 - S608
  • [4] Optimisation of TNF-Inhibitor Therapy for Rheumatoid Arthritis: Focus on Certolizumab Pegol
    BioDrugs, 2014, 28 (Suppl 1) : 1 - 1
  • [5] Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry
    Harrold, Leslie R.
    Reed, George W.
    Shewade, Ashwini
    Magner, Robert
    Saunders, Katherine C.
    John, Ani
    Kremer, Joel M.
    Greenberg, Jeffrey D.
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1090 - 1098
  • [6] How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol
    Torrente-Segarra, Vicenc
    Fernandez Prada, Manuel
    Exposito Moliner, Rosa
    Garrido Punal, Noemi Patricia
    Sanchez-Andrade Fernandez, Amalia
    Lamua Riazuelo, Jose Ramon
    Olive, Alejandro
    Tovar Beltran, Juan Victor
    Ferrandez, Jose Antonio Gonzalez
    Pastor, Carmen Moragues
    Arana, Ana Urruticoechea
    Rey, Jose Rey
    Cabello, Raul Veiga
    Diez, Angel Aragon
    Fuentes, Noelia Vazquez
    Cristobal, Anna Martinez
    Alonso, Ma del Pilar Navarro
    Palau, Sergi Ordonez
    Jimenez, Alejandro Munoz
    Martin, Jose Miguel Ruiz
    Pereira, Asuncion Acosta
    Aparicio, Angel Maria Garcia
    Fernandez, Jesus Carlos
    Morcillo, Mercedes
    Serret, Emilio Giner
    Palau, Nuria Montala
    Escalera, Carlos Rodriguez
    Esteban, Jose Campos
    de Oro, Juan Jose de Agustin
    Celimendiz, Pedro Giralt
    Vilchez, Desiree Ruiz
    Gonzalez-Albo, Silvia Paredes
    Courel, Laura Garrido
    Gonzalez, Carmen Olga Sanchez
    Guzman, Maria del Pilar Ahijado
    Perez, Patricia Castro
    Portales, Rosa Garcia
    Melon, Julia Fernandez
    Orfila, Gabriel Mercadal
    Pons, Jose Raul Noguera
    Tuduri, Concepcion Moll
    Armario, Ma Dolores Garcia
    Vila, Victor Eliseo Quevedo
    Garrido, Juan Jose Lerma
    Perez, Antonio Gracia
    Aguinaga, Elena Aurrecoechea
    Cid, Amalia Rueda
    Garcia, Marina Soledad Moreno
    Cortina, Eduardo Loza
    Torrent, Delia Taverner
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (02) : 395 - 398
  • [7] One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national US rheumatoid arthritis registry
    Harrold, Leslie R.
    Litman, Heather J.
    Saunders, Katherine C.
    Dandreo, Kimberly J.
    Gershenson, Bernice
    Greenberg, Jeffrey D.
    Low, Robert
    Stark, Jeffrey
    Suruki, Robert
    Jaganathan, Srihari
    Kremer, Joel M.
    Yassine, Mohamed
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [8] How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol
    Vicenç Torrente-Segarra
    Manuel Fernandez Prada
    Rosa Expósito Moliner
    Noemí Patricia Garrido Puñal
    Amalia Sánchez-Andrade Fernández
    José Ramón Lamua Riazuelo
    Alejandro Olivé
    Juan Víctor Tovar Beltrán
    Rheumatology International, 2019, 39 : 395 - 398
  • [9] Certolizumab Pegol Shows Longer Retention Rate in Comparison with Other TNF Inhibitors in Patients with Rheumatoid Arthritis and High Rheumatoid Factor Titers at Baseline. a Multicentre and Retrospective Study
    Lopez Medina, Clementina
    Calvo, Jerusalem
    Abalos-Aguilera, Maria del Carmen
    Cepas, Francisco
    Plasencia-Rodriguez, Chamaida
    Martinez Feito, Ana
    Balsa, Alejandro
    Fare-Garcia, Regina
    Juan Mas, Antonio
    Ruiz-Esquide, Virginia
    Sainz-Comas, Luis
    Diaz-Torne, Cesar
    Godoy, Javier
    Anon Onate, Isabel
    Mena Vazquez, Natalia
    Manrique, Sara
    Moreno Garcia, Marina Soledad
    Ortega Castro, Rafaela
    Escudero-Contreras, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2560 - 2562
  • [10] HOW GOOD ELDERLY RHEUMATOID ARTHRITIS PATIENTS RESPOND AT FIRST YEAR OF TREATMENT WITH CERTOLIZUMAB PEGOL?
    Torrente-Segarra, V.
    Prada, M. Fernandez
    Exposito, R.
    Punal, N. Garrido
    Sanchez-Andrade, A.
    Lamua-Riazuelo, J. R.
    Olive, A.
    Tovar, J. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 964 - 965
12345